Biology Reference
In-Depth Information
Huang, W.G., Cheng, A.L., Chen, Z.C., Peng, F., Zhang, P.F., Li, M.Y., et al., 2010. Targeted
proteomic analysis of 14-3-3 sigma in nasopharyngeal carcinoma. Int. J. Biochem. Cell
Biol. 42, 137-147.
Huettel, B., Kanno, T., Daxinger, L., Bucher, E., van der Winden, J., Matzke, A.J., et al., 2007.
RNA-directed DNA methylation mediated by DRD1 and Pol IVb: a versatile pathway for
transcriptional gene silencing in plants. Biochim. Biophys. Acta 1769, 358-374.
Hui, S.T.Y., Andres, A.M., Miller, A.K., Spann, N.J., Potter, D.W., Post, N.M., et  al., 2008.
Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc. Natl.
Acad. Sci. U.S.A. 105, 3921-3926.
Hummel, R., Watson, D.I., Smith, C., Kist, J., Michael, M.Z., Haier, J., et al., 2011. Mir-148a
improves response to chemotherapy in sensitive and resistant oesophageal adenocarci-
noma and squamous cell carcinoma cells. J. Gastroint. Surg. 15, 429-438.
Hurst, D.R., Edmonds, M.D., Scott, G.K., Benz, C.C., Vaidya, K.S., Welch, D.R., 2009a. Breast
cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer
metastasis. Cancer Res. 69, 1279-1283.
Hurst, J.H., Mendpara, N., Hooks, S.B., 2009b. Regulator of G-protein signalling expression
and function in ovarian cancer cell lines. Cell. Mol. Biol. Lett. 14, 153-174.
Iczkowski, K.A., 2011. Cell adhesion molecule CD44: its fnctional roles in prostate cancer.
Am. J. Transl. Res. 3, 1-7.
Ikeda, M., Hirabayashi, S., Fujiwara, N., Mori, H., Kawata, A., Iida, J., et  al., 2007. Ras-
association domain family protein 6 induces apoptosis via both caspase-dependent and
caspase-independent pathways. Exp. Cell Res. 313, 1484-1495.
Ikeda, M., Kawata, A., Nishikawa, M., Tateishi, Y., Yamaguchi, M., Nakagawa, K., et  al.,
2009. Hippo pathway-dependent and -independent roles of RASSF6. Sci. Signal. 2, ra59.
Ikeguchi, M., Yamaguchi, K., Kaibara, N., 2004. Clinical significance of the loss of KiSS-1
and orphan G-Protein-Coupled receptor ( hOT7T175 ) gene expression in esophageal
squamous cell carcinoma. Clin. Cancer Res. 10, 1379-1383.
Imajo, M., Miyatake, K., Iimura, A., Miyamoto, A., Nishida, E., 2012. A molecular mecha-
nism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling. EMBO
J. 31, 1109-1122.
Imam, J.S., Buddavarapu, K., Lee-Chang, J.S., Ganapathy, S., Camosy, C., Chen, Y., et  al.,
2010. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1
oncogene in human cancers. Oncogene 29, 4971-4979.
Imanaka, Y., Tsuchiya, S., Sato, F., Shimada, Y., Shimizu, K., Tsujimoto, G., 2011.
MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in
human esophageal squamous cell carcinoma. J. Hum. Genet. 56, 270-276.
Inaguma, S., Kasai, K., Ikeda, H., 2011. GLI1 facilitates the migration and invasion of pancreatic
cancer cells through MUC5AC-mediated attenuation of E-cadherin. Oncogene 30, 714-723.
Ingham, R.J., Colwill, K., Howard, C., Dsettwiler, S., Lim, C.S., Yu, J., et  al., 2005. WW
domains provide a platform for the assembly of multiprotein networks. Mol. Cell Biol.
25, 7092-7106.
Ingles-Esteve, J., Morales, M., Dalmases, A., Garcia-Carbonell, R., Jene-Sanz, A., Lopez-
Bigas, N., et al., 2012. Inhibition of specific NF-kappa B activity contributes to the tumor
suppressor function of 14-3-3 sigma in breast cancer. Plos ONE 7, e38347.
Iorio, M.V., Ferracin, M., Liu, C.G., Veronese, A., Spizzo, R., Sabbioni, S., 2005. MicroRNA
gene expression deregulation in human breast cancer. Cancer Res. 65, 7065-7070.
Ishizaki, K., Fujimoto, J., Kumimoto, H., Nishimoto, Y., Shimada, Y., Shinoda, M., et  al.,
2002. Frequent polymorphic changes but rare tumor specific mutations of the LATS2
gene on 13q11-12 in esophageal squamous cell carcinoma. Int. J. Oncol. 21, 1053-1057.
Search WWH ::




Custom Search